Publication highlights ImQuest’s Microbiology Capabilities
Data produced by ImQuest’s team was recently highlighted in mBio (an ASM Journal). ImQuest BioSciences has a strong track record of working our clients to accelerate their research and development needs, and produce publication quality data as part of these services. As noted in Shahsavari et al, “Macromolecular incorporation assay was performed as a service by ImQuest Biosciences. E. coli W0153 strain” as a component of our services to identify compound mechanism of action. Various endpoints of bacterial biosynthetic pathways were evaluated, and were useful in identifying compound mechanism.
Antibacterial testing services are available at ImQuest for the evaluation of small molecules, natural products, immune modulators, biologics and therapeutic antibodies and provide necessary support from initial discovery, structure-activity relationship evaluation, lead identification and IND-directed preclinical development.
Contact us for more information.